摘要
目的研究开喉剑在治疗疱疹性咽峡炎中的疗效。方法选取在2015年1月—2016年6月时间内来该院疱疹性咽峡炎的患儿192例,随后分为常规抗病毒治疗组与联用开喉剑治疗组。其中医师对常规抗病毒治疗组患者采取常规抗病毒药物进行治疗,而医师对联用开喉剑治疗组患者联合使用开喉剑药物进行治疗。结果联用开喉剑治疗组与常规抗病毒治疗组患者的临床体征消退时间以及不良反应发生情况等数据差异较为显著,前者[(3.68±0.21)d,(2.38±0.15)d,(2.09±0.16)d,(3.42±0.18)d,1.0%]显著优于后者[(5.03±0.16)d,(3.79±0.21)d,(3.27±0.13)d,(5.48±0.21)d,7.5%],差异有统计学意义(t=2.265 4,2.212 1,3.512 5,5.632 1,χ~2=2.351 2,P<0.05)。结论开喉剑在治疗疱疹性咽峡炎中的疗效显著,值得进一步推广。
Objective To study the curative effect of kaihoujian in treatment of herpangina. Methods 192 cases of children with herpangina in our hospital from January 2015 to June 2016 were selected, and randomly divided into two groups, the routine anti-viral treatment group used the routine anti-viral drugs, while the combined group used the anti-viral therapy combined with kaihoujian. Results The regression time of clinical vital signs and occurrence of adverse reactions in the routine anti-viral treatment group were obviously better than those in the combined group,[(3.68±0.21)d,(2.38±0.15)d,(2.09±0.16)d,(3.42±0.18)d, 1.0% vs (5.03±0.16)d,(3.79±0.21)d,(3.27±0.13)d,(5.48±0.21)d, 7.5%], with statistical significance (t=2.265 4,2.212 1,3.512 5,5.632 1,χ^2=2.351 2, P<0.05). Conclusion The curative effect of kaihoujian in treatment of herpangina is obvious, which is worth further promotion.
作者
陆燕琴
LU Yan-qin(Department of Pediatrics,Changzhou Wujin People’s Hospital,Changzhou,Jiangsu Province,213002 China)
出处
《系统医学》
2018年第22期86-88,共3页
Systems Medicine
关键词
开喉剑
疱疹性咽峡炎
疗效
Kaihoujian
Herpangina
Curative effect